Abstracts tagged "osteoporosis and randomized trials"

Abstract Number: 371 • 2015 ACR/ARHP Annual Meeting
New Vertebral Fractures after Vertebroplasty: Two Year Results from a Randomised Placebo-Controlled Trial
Margaret P. Staples¹, B Matthew Howe², Michael Ringler², Peter Mitchell³, Chris Wriedt⁴, John Wark⁵, Peter Ebeling⁶, Richard Osborne⁷, David Kallmes² and Rachelle Buchbinder⁸, ¹Monash Department of Clinical Epidemiology, Cabrini Institute and Monash University, Malvern, Australia, ²Department of Radiology, Mayo Clinic College of Medicine, Rochester, MN, ³Department of Radiology, The University of Melbourne, Royal Melbourne Hospital, Melbourne, Australia, ⁴MIA Radiology, Melbourne, Australia, ⁵Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Melbourne, Australia, ⁶Department of Medicine, Monash University, Monash Medical Centre, Melbourne, Australia, ⁷Public Health Innovation, Deakin University, Melbourne, Australia, ⁸Monash Department of Clinical Epidemiology, Cabrini Institute and Monash University, Melbourne, Australia
Background/Purpose: We previously reported the results of a randomized participant and outcome assessor blinded controlled trial that found no beneficial effect of vertebroplasty (VP) over…
Abstract Number: 920 • 2012 ACR/ARHP Annual Meeting
A Multimodal Intervention to Improve Osteoporosis Care in Home Health Settings: Results From a Cluster Randomized Trial
Meredith Kilgore¹, Kenneth G. Saag², Jeroan Allison³, Elizabeth Kitchin⁴, Julie L. Locher¹, Amy Mudano⁵, Ryan C. Outman⁶ and Jeffrey R. Curtis⁷, ¹Health Care Organization & Policy, University of Alabama at Birmingham, Birmingham, AL, ²Div Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, ³Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, ⁴Nutrition Sciences, Birmingham, AL, ⁵Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, ⁶Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, ⁷Rheumatology & Immunology, Univ of Alabama-Birmingham, Birmingham, AL
Background/Purpose: Although very effective osteoporosis treatments are available, the rates of use are low, even among individuals who have already experienced a fracture and are…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].